Tenofovir Alafenamide With Fine Needle Aspiration Biopsy in Chronic Hepatitis B:
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to identify immunological mechanisms that contribute to
normalization of liver inflammation in chronic hepatitis B (CHB) patients starting the
antiviral nucleoside analogue, Tenofovir alafenamide (TAF).